The presentation will focus on the use of receptor-mediated targeted drug delivery to deliver large molecules to the brain for Alzheimer's disease. Specifically, the presentation will cover ...
This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB ...
MyTACTIC: Afficacy and safety of atezolizumab (atezo) + chemotherapy (chemo) in patients (pts) with advanced unresectable/metastatic solid tumors with high tumor ...
Iron intake and soluble transferrin receptor were positively associated with insulin resistance, whereas serum iron and transferrin receptor were negatively associated. Disturbances in iron metabolism ...
FDA accelerated approval positions Avlayah as the first therapy engineered to cross the blood–brain barrier for MPS ...
In an important step toward more effective gene therapies for brain diseases, researchers have engineered a gene-delivery vehicle that uses a human protein to efficiently cross the blood-brain barrier ...
Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results